DNA X enters USD 3.05 million convertible note financing with DNA Holdings Venture

DNA X

DNA X

SONM

0.00
  • DNA X entered a Securities Purchase Agreement with DNA Holdings Venture for a USD 3.05 million convertible promissory note, closing May 26.
  • Financing comprised USD 1.8 million cash, refinancing a USD 1.2 million December 2025 note, including USD 52,787.68 accrued interest.
  • Note matures Dec. 31, 2026. Interest rate 10%.
  • Convertible at holder’s option at USD 6 per share, subject to stockholder approval. Default pricing resets to 80% of market at conversion.
  • Debt secured by a first-priority lien on membership interests in wholly owned subsidiary DNA X, LLC. Related amendment terminated a prior put option.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. DNA X Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-025433), on May 27, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.